1. Home
  2. KALA vs POAS Comparison

KALA vs POAS Comparison

Compare KALA & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$3.04

Market Cap

2.5M

Sector

Health Care

ML Signal

N/A

Logo Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$3.09

Market Cap

2.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
KALA
POAS
Founded
2009
2017
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.3M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
KALA
POAS
Price
$3.04
$3.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
164.5K
★ 2.9M
Earning Date
12-01-2026
08-31-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 67.39
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.13
52 Week High
$191.00
$7.40

Technical Indicators

Market Signals
Indicator
KALA
POAS
Relative Strength Index (RSI) 77.25 66.83
Support Level $2.07 $0.27
Resistance Level $3.71 $5.60
Average True Range (ATR) 0.14 0.80
MACD 0.38 0.17
Stochastic Oscillator 73.26 51.52

Price Performance

Historical Comparison
KALA
POAS

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers high tech microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

Share on Social Networks: